Insecticides (India) Limited (IIL) reported a 12% year-on-year decline in consolidated revenue to Rs. 612 crore for the quarter ended June 30, 2026, as deficient rainfall across India weighed on crop protection demand.
The company’s revenue stood at Rs. 691 crore in Q1FY26. Despite the decline in topline, IIL expanded its gross profit margin by 240 basis points year-on-year to 31.6%, helped by disciplined pricing actions.
Profitability, however, remained under pressure. EBITDA fell 20% to Rs. 68 crore, from Rs. 85 crore a year earlier, while EBITDA margin narrowed to 11.1% from 12.2%. Profit after tax declined 24% to Rs. 44 crore, compared with Rs. 58 crore in Q1FY26.
IIL used the quarter to strengthen its premium product portfolio, including the pan-India launch of GRANUVIA, a next-generation insecticide introduced in collaboration with Corteva Agriscience. The launch was backed by extensive engagement with distributors, dealers and farmers.
The company also introduced Spinoace during the quarter as part of the collaboration.
Meanwhile, KAEROS continued to gain momentum, with IIL expanding its portfolio and distribution footprint and positioning the platform as a key growth lever.
The company said it plans to double its IIL Crop Solutions (ICS) plots from the current 36, covering rice, cotton, chilli and soybean across 14 states. The expansion follows strong farmer acceptance and demonstrated return on investment from the existing plots.
IIL also stepped up its farmer engagement efforts during the quarter, conducting more than 3,600 farmer meetings, 600 field days, 1,400 demonstrations and 15,000 farmer visits.
Commenting on the results, Rajesh Kumar Aggarwal, MD of Insecticides (India) Ltd., said: "We delivered a resilient performance during the quarter despite a subdued demand, supported by our diversified product portfolio, presence across key crops, strong execution capabilities, and clear strategic direction.
"While deficient rainfall impacted near-term revenue, pricing discipline and operating efficiencies helped stability in gross margin. With an improving macro environment and focused execution, we remain confident of progressively building momentum through the coming quarters.”
He added: "Our confidence is supported by the benefits emerging from sustained investments in premiumization, manufacturing, research, digital transformation, and global partnerships. The continued expansion of our Focus Maharatna and Maharatna portfolios, supported by collaborations with leading global innovators, is strengthening margins, deepening farmer engagement, enhancing the overall quality of growth. Additionally, Kaeros Research is evolving into a significant growth platform and the Company is advancing its international business footprint.
“Supported by capacity expansion, backward integration, and operational excellence, we are building a more resilient and future-ready organization. We remain committed to delivering sustainable, high-quality growth and creating enduring value for farmers, partners, employees, and shareholders.”
